Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2

The heterologous ChAd/BNT combination confers better protection against SARS-CoV-2 infection than the homologous BNT/BNT combination in a real-world observational study of healthcare workers.

Related Keywords

Chad , France , Alessandrobiascioli Shutterstock , Nidhi Saha , Astrazeneca Chadox , , Hospices Civils De Lyon , Binding Domain , Coronavirus Disease Covid 19 , Efficacy , Healthcare , D4 , Fell , Coronavirus , Homologous , Hospital , Immunity , Medicine , Espiratory , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Vaccine ,